Candriam Equities L Oncology Fund Class BF Fonds
2.314,50
EUR
+48,77
EUR
+2,15
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 7,34% |
| AstraZeneca PLC | GB0009895292 | 5,01% |
| Merck & Co Inc | US58933Y1055 | 4,38% |
| Novo Nordisk AS Class B | DK0062498333 | 4,31% |
| Gilead Sciences Inc | US3755581036 | 4,29% |
| Thermo Fisher Scientific Inc | US8835561023 | 4,17% |
| Roche Holding AG | CH0012032048 | 4,01% |
| Novartis AG Registered Shares | CH0012005267 | 3,33% |
| Intuitive Surgical Inc | US46120E6023 | 3,20% |
| Amgen Inc | US0311621009 | 3,12% |
| Sonstige | 56,83% |